美股市场个股详情
REGN 再生元制药公司
- 754.870
- +1.840+0.24%
收盘价 11/27 16:00 (美东)
- 754.870
- 0.0000.00%
盘后 20:01 (美东)
829.52亿总市值18.67市盈率TTM
762.160最高价749.515最低价54.48万股成交量756.720今开753.030昨收4.12亿成交额0.52%换手率21.71市盈率(静)1.10亿总股本1211.20052周最高2.83市净率795.69亿流通值735.95552周最低--股息TTM1.05亿流通股1211.200历史最高--股息率TTM1.68%振幅4.610历史最低755.961平均价1股每手
关于再生元制药公司公司
再生元制药公司是一家从事药物发现、发明、开发、制造和商业化的生物技术公司。其产品组合包括以下品牌:EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST和ZALTRAP。该公司通过其专有的VelociSuite技术加速了传统药物的开发过程，例如VelocImmune，该技术使用独特的基因人源化小鼠来生产优化的全人抗体和双特异性抗体。
公司介绍
公司代码REGN
公司名称再生元制药公司
上市日期1991/04/02
发行价格22.00
成立日期1988
CEODr. Leonard S. Schleifer,M.D.,PhD
所属市场纳斯达克
员工数量13450
年结日12-31
公司地址777 Old Saw Mill River Road
城市Tarrytown
省份纽约州
国家美国
邮编10591-6707
电话1-914-847-7000
董事高管
- 姓名
- 职务
- 年薪
- Dr. Leonard S. Schleifer,M.D.,PhD
- Co-Chairman of the Board, Co-President and Chief Executive Officer
- 818.43万
- Christopher R. Fenimore
- Senior Vice President, Finance and Chief Financial Officer
- --
- Dr. George D. Yancopoulos,M.D.,PhD
- Co-Chairman of the Board, Co-President and Chief Scientific Officer
- 775.98万
- Daniel P. Van Plew
- Executive Vice President and General Manager, Industrial Operations and Product Supply
- 876.01万
- Joseph J. Larosa
- Executive Vice President, General Counsel and Secretary
- --
- Dr. Neil Stahl,PhD
- Executive Vice President, Research and Development
- --
- Jason Pitofsky
- Vice President and Controller
- --
- Andrew J Murphy
- Executive Vice President, Research
- 842.93万
- Marion McCourt
- Executive Vice President, Commercial
- --
- Kathryn Guarini, PhD
- Director
- 103.12万
- Dr. David P. Schenkein, M.D.
- Director
- 103.12万
- Dr. Huda Y. Zoghbi, M.D.
- Independent Director
- 71.50万
- George L. Sing
- Independent Director
- 72.50万
- Dr. Michael S. Brown, M.D.
- Independent Director
- 72.90万
- Dr. Craig B. Thompson,M.D.
- Independent Director
- 24.78万
- Dr. Joseph L. Goldstein,M.D.
- Independent Director
- 71.00万
- Christine A. Poon
- Lead Independent Director
- 74.80万
- Dr. Bonnie L. Bassler, PhD
- Independent Director
- 71.00万
- Dr. N. Anthony Coles, M.D.
- Independent Director
- 70.50万
- Arthur Frederick Ryan
- Independent Director
- 72.50万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
